Comparing User Satisfaction and Effectiveness of Conventional AirSense 10 CPAP Versus Portable AirMini CPAP in Adults with Moderate to Severe Obstructive Sleep Apnea

What this Trial Is About

Obstructive sleep apnea OSA is a widespread health concern characterized by underdiagnosis, especially among adults. Obesity is a major risk factor for developing OSA, and its rising prevalence globally and in Malaysia contributes significantly to this problem. OSA can lead to serious cardiovascular and neurocognitive effects, including hypertension, insulin resistance, heart failure, poor concentration, memory loss, and increased risk of accidents. This study is a randomized crossover trial comparing two types of CPAP devices the conventional AirSense 10 and the portable AirMini. Participants with moderate to severe OSA will use each device for 7 days in random order. The study aims to assess user satisfaction, air leak, comfort, portability, maintenance, and treatment efficacy measured by reductions in apnea-hypopnea index AHI and required pressure levels. Participants will undergo a sleep study to confirm their OSA diagnosis and then be randomized to start with either CPAP device. After each 7-day usage period, they will complete questionnaires rating their experience with the devices. Data on device effectiveness and user satisfaction will be collected and analyzed. The total participation time involves two consecutive 7-day treatment periods with assessments at the end of each period.

Comparative Assessment of Sleep Positive Airway Pressure Modalities (CASPAM)